WNK1 regulates skeletal muscle cell hypertrophy by modulating the nuclear localization and transcriptional activity of FOXO4

[1]  A. Ammar,et al.  Generation A , 2022 .

[2]  T. G. Barbosa-Silva,et al.  Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People , 2019, European Journal of Clinical Nutrition.

[3]  Y. Guan,et al.  WNK1 is required for proliferation induced by hypotonic challenge in rat vascular smooth muscle cells , 2017, Acta Pharmacologica Sinica.

[4]  N. Proudfoot,et al.  WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription , 2017, Genes & development.

[5]  S. Anker,et al.  Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016. , 2017, International journal of cardiology.

[6]  N. Fujii,et al.  Loop diuretics affect skeletal myoblast differentiation and exercise-induced muscle hypertrophy , 2017, Scientific Reports.

[7]  S. Takeda,et al.  WNK4 is an Adipogenic Factor and Its Deletion Reduces Diet-Induced Obesity in Mice , 2017, EBioMedicine.

[8]  Y. Yoshizaki,et al.  KLHL3 Knockout Mice Reveal the Physiological Role of KLHL3 and the Pathophysiology of Pseudohypoaldosteronism Type II Caused by Mutant KLHL3 , 2017, Molecular and Cellular Biology.

[9]  M. Cobb,et al.  Multistep regulation of autophagy by WNK1 , 2016, Proceedings of the National Academy of Sciences.

[10]  Y. Yagi,et al.  Small-molecule WNK inhibition regulates cardiovascular and renal function. , 2016, Nature chemical biology.

[11]  A. Alazami,et al.  A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies , 2016, Human Genomics.

[12]  J. Xie,et al.  WNK1 kinase balances T cell adhesion versus migration in vivo , 2016, Nature Immunology.

[13]  Jizhong Cheng,et al.  Serum Glucocorticoid-Regulated Kinase 1 Blocks CKD-Induced Muscle Wasting Via Inactivation of FoxO3a and Smad2/3. , 2016, Journal of the American Society of Nephrology : JASN.

[14]  T. Rai,et al.  Generation of Hypertension-Associated STK39 Polymorphism Knockin Cell Lines With the Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 System , 2015, Hypertension.

[15]  P. Urbánek,et al.  Redox regulation of FoxO transcription factors , 2015, Redox biology.

[16]  S. Alper,et al.  Inhibition of WNK3 Kinase Signaling Reduces Brain Damage and Accelerates Neurological Recovery After Stroke , 2015, Stroke.

[17]  C. Stewart,et al.  Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake , 2015, Aging cell.

[18]  M. Englesbe,et al.  Implications of sarcopenia in major surgery. , 2015, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[19]  S. Alper,et al.  Inhibition of WNK 3 Kinase Signaling Reduces Brain Damage and Accelerates Neurological Recovery After Stroke , 2015 .

[20]  M. Hawkins,et al.  Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[21]  S. Bodine,et al.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. , 2014, American journal of physiology. Endocrinology and metabolism.

[22]  S. Uchida.  Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases , 2014, Current opinion in nephrology and hypertension.

[23]  C. Yuh,et al.  Zebrafish WNK Lysine Deficient Protein Kinase 1 (wnk1) Affects Angiogenesis Associated with VEGF Signaling , 2014, PloS one.

[24]  D. Alessi,et al.  The WNK-SPAK/OSR1 pathway: Master regulator of cation-chloride cotransporters , 2014, Science Signaling.

[25]  S. Sasaki,et al.  WNK4 is the major WNK positively regulating NCC in the mouse kidney , 2014, Bioscience reports.

[26]  Y. Hata,et al.  Screening with a Novel Cell-Based Assay for TAZ Activators Identifies a Compound That Enhances Myogenesis in C2C12 Cells and Facilitates Muscle Repair in a Muscle Injury Model , 2014, Molecular and Cellular Biology.

[27]  N. Perrimon,et al.  The influence of skeletal muscle on systemic aging and lifespan , 2013, Aging cell.

[28]  R. Candau,et al.  FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis , 2013, Cellular and Molecular Life Sciences.

[29]  S. Sasaki,et al.  Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through different molecular mechanisms. , 2013, Biochemical and biophysical research communications.

[30]  C. Scavone,et al.  Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  H. Kawaguchi,et al.  Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension. , 2013, Cell reports.

[32]  J. Xie,et al.  WNK1 Protein Kinase Regulates Embryonic Cardiovascular Development through the OSR1 Signaling Cascade* , 2013, The Journal of Biological Chemistry.

[33]  D. Alessi,et al.  SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation , 2011, The Biochemical journal.

[34]  K. Luby-Phelps,et al.  WNK1 is required for mitosis and abscission , 2011, Proceedings of the National Academy of Sciences.

[35]  A. Russell,et al.  The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy , 2011, Pflügers Archiv - European Journal of Physiology.

[36]  R. DePinho,et al.  The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. , 2010, The Journal of clinical investigation.

[37]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[38]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[39]  W. Mitch,et al.  Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. , 2009, Kidney international.

[40]  J. Xie,et al.  Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice. , 2009, The American journal of pathology.

[41]  R. DePinho,et al.  A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. , 2007, The Journal of clinical investigation.

[42]  H. Shibuya,et al.  Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. , 2007, Cell metabolism.

[43]  E. Kinoshita,et al.  Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins*S , 2006, Molecular & Cellular Proteomics.

[44]  H. Matsuzaki,et al.  Regulation of intracellular localization and transcriptional activity of FOXO4 by protein kinase B through phosphorylation at the motif sites conserved among the FOXO family. , 2005, Journal of biochemistry.

[45]  X. Jeunemaître,et al.  Multiple Promoters in the WNK1 Gene: One Controls Expression of a Kidney-Specific Kinase-Defective Isoform , 2003, Molecular and Cellular Biology.

[46]  H. Mayan,et al.  Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. , 2002, The Journal of clinical endocrinology and metabolism.

[47]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[49]  Robert J. Unwin,et al.  Human Hypertension Caused by Mutations in WNK Kinases , 2001, Science.

[50]  Y. Nishizuka,et al.  Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Geert J. P. L. Kops,et al.  Direct control of the Forkhead transcription factor AFX by protein kinase B , 1999, Nature.

[52]  I. Rosenberg,et al.  Sarcopenia: origins and clinical relevance. , 1997, The Journal of nutrition.

[53]  S. Kaname,et al.  [Gordon's syndrome]. , 1992, Nihon rinsho. Japanese journal of clinical medicine.

[54]  R. Gordon.  The syndrome of hypertension and hyperkalemia with normal glomerular filtration rate: Gordon's syndrome. , 1986, Australian and New Zealand journal of medicine.